Amphastar Pharmaceuticals CEO Jack Zhang's 2019 pay rises 2% to $6M
Amphastar Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 15, 2020
Amphastar Pharmaceuticals reported fiscal year 2019 executive compensation information on April 15, 2020.
In 2019, five executives at Amphastar Pharmaceuticals received on average a compensation package of $3M, a 22% decrease compared to previous year.
Average pay of disclosed executives at Amphastar Pharmaceuticals
Jack Yongfeng Zhang, Chief Executive Officer, received $6M in total, which increased by 2% compared to 2018. 33% of Zhang's compensation, or $2M, was in stock awards. Zhang also received $394K in bonus, $681K in non-equity incentive plan, $2M in option awards, $898K in salary, as well as $18K in other compensation.
Mary Ziping Luo, Chief Operating Officer, received a compensation package of $3M, which decreased by 2% compared to previous year. 28% of the compensation package, or $840K, was in stock awards.
Jason B. Shandell, General Counsel, earned $2.9M in 2019, a 13% increase compared to previous year.
William J. Peters, Chief Financial Officer, received $2M in 2019.
Rong Zhou, Executive Vice President of Production and President of Armstrong Pharmaceuticals, Inc, earned $1.1M in 2019.
Related executives
Jack Zhang
Amphastar Pharmaceuticals
Chief Executive Officer
William Peters
Amphastar Pharmaceuticals
Chief Financial Officer
Mary Luo
Amphastar Pharmaceuticals
Chief Operating Officer
Jason Shandell
Amphastar Pharmaceuticals
General Counsel
Rong Zhou
Amphastar Pharmaceuticals
Executive Vice President of Production and President of Armstrong Pharmaceuticals, Inc
You may also like
Source: SEC filing on April 15, 2020.